AA
TLSIW icon

AQR Arbitrage’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

AQR Arbitrage’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-66,665
Closed -$2.79K – 819
2023
Q2 		$2.79K Hold
66,665
– – ﹤0.01% 843
2023
Q1 		$4.09K Hold
66,665
– – ﹤0.01% 968
2022
Q4 		$5K Hold
66,665
– – ﹤0.01% 1019
2022
Q3 		$4K Hold
66,665
– – ﹤0.01% 1277
2022
Q2 		$6K Hold
66,665
– – ﹤0.01% 1323
2022
Q1 		$17K Hold
66,665
– – ﹤0.01% 1153
2021
Q4 		$659K Hold
66,665
– – 0.02% 793
2021
Q3 		$55K Hold
66,665
– – ﹤0.01% 900
2021
Q2 		$66K Hold
66,665
– – ﹤0.01% 902
2021
Q1 		$73K Buy
+66,665
New +$120K ﹤0.01% 865

Other funds holding TLSIW

MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

AQR Arbitrage's TLSIW Position: Q3 2023 in Review

AQR Arbitrage sold out of TriSalus Life Sciences Warrant (TLSIW) in Q3 2023, closing a stake of 66,665 shares — an estimated $2.79K sold.

AQR Arbitrage first reported a position in TLSIW in Q1 2021 and held it in 10 quarters. The position peaked at $659K in Q4 2021. 19 funds tracked by Wall St. Rank hold TLSIW as of Q3 2023.

  • AQR Arbitrage reported no remaining TriSalus Life Sciences Warrant position as of Q3 2023 after selling out during the quarter.
  • AQR Arbitrage sold 66,665 TriSalus Life Sciences Warrant shares in Q3 2023, an estimated $2.79K.
  • AQR Arbitrage first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 10 quarters.
  • AQR Arbitrage's TriSalus Life Sciences Warrant position peaked at $659K in Q4 2021.
  • 19 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q3 2023.

Based on AQR Arbitrage's 13F filing for Q3 2023, filed 14 Nov 2023.